CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 118 enrolled
Drug / intervention
Tatsu/Tradewind Investigational BG Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01447121
NCT01447121N/ACompleted
CompareCT.gov

Tatsu/Tradewind System User Performance Evaluation

Ascensia Diabetes Care·interventional·Posted Oct 6, 2011·Updated Feb 29, 2016

In Brief

A clinical study evaluating Tatsu/Tradewind Investigational BG Monitoring System for Diabetes. Completed, enrolled 118 participants across 1 site.

Detailed Summary

This clinical trial is designed to assess an investigational blood glucose monitoring system with fingerstick blood in the hands of untrained intended users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 6, 2011
Enrollment StartSep 1, 2011
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 14.7 years ago

Interventions

Tatsu/Tradewind Investigational BG Monitoring Systemdevice

Tradewind is a Bayer investigational meter that used an investigational sensor.